Zobrazeno 1 - 10
of 577
pro vyhledávání: '"Casella-Filho A"'
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 46, Iss 5, Pp 454-459 (2013)
A low concentration of nitric oxide associated with a high concentration of asymmetric dimethylarginine (ADMA) can explain the lack of ischemic cardioprotection observed in the presence of hypercholesterolemia. The objective of the present study was
Externí odkaz:
https://doaj.org/article/d53d2ab839fc473a9bb268621ac54ed0
Autor:
R.D. Santos, A.C.M. Gagliardi, H.T. Xavier, A. Casella Filho, D.B. Araújo, F.Y. Cesena, R.J. Alves, et al
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 99, Iss 2 suppl 2, Pp 1-28 (2012)
Externí odkaz:
https://doaj.org/article/0cde67bcf5f84d6391452b2ff9bb2e29
Autor:
P.M.M. Dourado, J.M. Tsutsui, M.B.P. Landim, A. Casella Filho, T.F.G. Galvao, V.D. Aiello, W. Mathias Jr., P.L. da Luz, A.C.P. Chagas
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 44, Iss 5, Pp 469-476 (2011)
Dyslipidemia is related to the progression of atherosclerosis and is an important risk factor for acute coronary syndromes. Our objective was to determine the effect of rosuvastatin on myocardial necrosis in an experimental model of acute myocardial
Externí odkaz:
https://doaj.org/article/ed1a45916cc64dba905aac8f14e4fedf
Autor:
Casella-Filho, Antonio, Chagas, Antonio Carlos P., Maranhão, Raul C., Trombetta, Ivani C., Cesena, Fernando H.Y., Silva, Vanessa M., Tanus-Santos, Jose Eduardo, Negrão, Carlos E., da Luz, Protasio L.
Publikováno v:
In The American Journal of Cardiology 2011 107(8):1168-1172
Publikováno v:
Clinics, Vol 64, Iss 5, Pp 471-478 (2009)
Atherosclerotic coronary heart disease is the leading cause of morbidity and mortality in industrialized countries, and endothelial dysfunction is considered a precursor phenomenon. The nitric oxide produced by the endothelium under the action of end
Externí odkaz:
https://doaj.org/article/e3d2a5d33bd246609110e1f6bfece2c1
Publikováno v:
Clinics, Vol 63, Iss 5, Pp 573-580 (2008)
OBJECTIVES: 1) To evaluate the compliance with drug treatment in patients with metabolic syndrome. 2) To determine association between access to and use of medicines, as well as the level of knowledge of cardiovascular risk factors and compliance. IN
Externí odkaz:
https://doaj.org/article/9b4e24fb2cbc4bf49e7c32b03670d73f
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 85, Pp 20-24 (2005)
Ezetimiba é um inibidor da absorção do colesterol que é glucuronidado no fígado após sua rápida absorção nos enterócitos, onde juntamente com os seus metabólitos, exerce as suas ações hipolipidêmicas, reduzindo a absorção do colestero
Externí odkaz:
https://doaj.org/article/2d32a44cda824127b279fab868ac0be4
Autor:
Gonçalves, Flavia M., Jacob-Ferreira, Anna L.B., Gomes, Valeria A., Casella-Filho, Antonio, Chagas, Antonio C.P., Marcaccini, Andrea M., Gerlach, Raquel F., Tanus-Santos, Jose E.
Publikováno v:
In Clinica Chimica Acta 2009 403(1):173-177
Autor:
Lopes, Nilcéia, Zanini, Antonio Carlos, Casella-Filho, Antonio, Chagas, Antonio Carlos Palandri
Publikováno v:
In Clinics October 2008 63(5):573-580
Autor:
Antonio Casella Filho, Wilson Mathias Junior, João Paulo de Almeida Dourado, Leonardo Roever, Paulo Magno Martins Dourado Jeane Mike Tsutsui, Larissa de Almeida Dourado
Publikováno v:
Archive of Biomedical Science and Engineering. 3:001-010
Stress Echocardiography is an established technique used all over the world as a non invasive evaluation of patients with coronary artery disease (CAD) and also an important method to evaluate myocardial viability and the contractile reserve.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::451bb07b85df5df5f22ab07279ea07d6
https://doi.org/10.17352/abse.000007
https://doi.org/10.17352/abse.000007